Andrew Guggenhime, PRESIDENT AND CFO at Vaxcyte, Inc. (PCVX), sold 10,000 shares at $53.00 ($530K) on 2026-06-18, disclosed to the SEC on 2026-06-18.
Scheduled sale ($530k) by PRESIDENT AND CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| PCVX | SELL | 2025-02-19 | $1.3M | — | Filing → |
| PCVX | SELL | 2025-01-22 | $1.4M | — | Filing → |
| PCVX | SELL | 2024-12-19 | $1.4M | — | Filing → |